Tag: materials science
-
Patent Awarded for Nasal Delivered Cancer Immunotherapy
A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent.
-
Self-Repair Developed for Soft Materials Circuits
Materials scientists and engineers developed the ability for electronic circuits in soft materials, like those found in wearable devices, to repair themselves if ruptured.
-
Infographic – Graphene Investment in Decline
In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out.
-
Lilly, Cell Implants Start-Up Partner on Diabetes
Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases.
-
Hydrogel, Solar Power Provide Simple Water Purification
An engineering lab demonstrates how polymer gels and ambient sunlight can provide a simple, inexpensive alternative to current complex and expensive technologies for desalinating or purifying drinking water.
-
Nanotech Pain Drug Formulations Developed
A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs.
-
Paper Art Form Boosts Bandage, Wearables Adhesion
An engineering lab adapted the traditional Japanese art form of kirigami to create a surface for bandages and wearable devices on knees and elbows that bend a great deal and thus are difficult to stay on.
-
Patent Awarded for Nanoparticle Drug, Cannabis Delivery
A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments.
-
Novartis Licenses Biomaterial for Cancer Immunotherapy
Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer.
-
Peptide Hydrogel Boosts Cancer Immunotherapies
A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses.